Silencing DRP1 or overexpressing Mfn1 led to mitochondrial elongation or clustering, respectively, significantly inhibiting the metastatic ability of breast cancer cells (Zhao et al. 2013). The gene discussed is DNM1L; the disease is breast carcinoma.